These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11550499)

  • 1. [Effect of pefloxacin on immune response].
    Artsimovich NG; Nastoiashchaia NN; Navashin PS
    Antibiot Khimioter; 2001; 46(4):11-2. PubMed ID: 11550499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multifactor analysis of the effect of pefloxacin on the dynamics of antibody synthesis to EV vaccine fraction 1 and hemagglutinins].
    Smolkina TB; Iordanova AI; Iudin SM; Nikitin AV
    Antibiot Khimioter; 1995 Feb; 40(2):36-40. PubMed ID: 7605142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of new quinolones on normal immune capabilities.
    Tawfik AF; Shoeb HA; Bishop SJ; al-Shammary FJ; Shibl AM
    J Chemother; 1990 Oct; 2(5):300-5. PubMed ID: 2090768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of pharmacodynamic parameters of pefloxacin on elastase and protease activity in Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1996 Sep; 45(3):119-22. PubMed ID: 8998604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):28-30. PubMed ID: 11038674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence.
    Aquilini D; Bartoloni A; Paradisi F
    J Chemother; 1991 Jan; 3 Suppl 1():116-8. PubMed ID: 12041743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of 2-methyl-4-amino-6-hydroxypyrimidine on delayed hypersensitivity].
    Ismagilova AF; Zarudiĭ FS; Davydova VA; Lazareva DN
    Eksp Klin Farmakol; 1997; 60(1):45-6. PubMed ID: 9162284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interrelations of cellular and humoral immune response and different doses of sheep erythrocytes in mice].
    Gusev EIu; Ponosov VL; Kevorkov NN
    Biull Eksp Biol Med; 1991 Sep; 112(9):271-3. PubMed ID: 1747474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
    Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
    Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of rubomycin and carminomycin on the delayed hypersensitivity reaction in mice immunized with ram erythrocytes].
    Vatin AE
    Antibiotiki; 1981 Oct; 26(10):750-3. PubMed ID: 6975599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of asymmetry of nervous and immune systems in the formation of cellular immunity of (CBaxC57Bl/6) F1 mice.
    Gontova IA; Abramov VV; Kozlov VA
    Neuroimmunomodulation; 2004; 11(6):385-91. PubMed ID: 15467354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pefloxacin activity against recent clinical isolates.
    Lembo M; Covelli B; Nani E; Lavitola A
    J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial activity of pefloxacin in comparison with other quinolones].
    Darenkov AF; Kotliarova GA; Kondrat'eva EM
    Antibiot Khimioter; 1991 Nov; 36(11):24-6. PubMed ID: 1793290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of Yersinia pseudotuberculosis to pefloxacin].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1995 Jul; 40(7):22-4. PubMed ID: 8645054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppression of delayed hypersensitivity in mice receiving a massive dose of xenogeneic erythrocytes].
    Chernousov AD; Fontalin LN
    Biull Eksp Biol Med; 1979 Dec; 88(12):693-5. PubMed ID: 160253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
    Wang JX; Tang W; Shi LP; Wan J; Zhou R; Ni J; Fu YF; Yang YF; Li Y; Zuo JP
    Br J Pharmacol; 2007 Mar; 150(5):652-61. PubMed ID: 17262016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.